The Brd-Inhibitor OTX015 Shows Pre-Clinical Activity in Anaplastic Large T-Cell Lymphoma (ALCL)

被引：1
|
作者：
Boi, Michela [1 ]
Bonetti, Paola [1 ]
Ponzoni, Maurilio [2 ,3 ]
Tibiletti, Maria Grazia [4 ]
Stathis, Anastasios [5 ]
Cvitkovic, Esteban [6 ]
Inghirami, Giorgio [7 ]
Zucca, Emanuele [5 ]
Bertoni, Francesco [8 ]
机构：
[1] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland
[2] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Unit Lymphoid Malignancies, I-20132 Milan, Italy
[4] Insubria Univ, Varese, Italy
[5] IOSI Oncol Inst So Switzerland, Bellinzona, Switzerland
[6] OncoEthix SA, Lausanne, Switzerland
[7] Univ Turin, Ctr Expt Res & Med Studies, Turin, Italy
[8] Oncol Inst So Switzerland IOSI, Lymphoma Unit, Bellinzona, Switzerland
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4872.4872
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4872
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Expression of linker for activation of T-cells (LAT) protein in peripheral T-cell (PTCL) and T/null anaplastic large cell (ALCL) lymphoma
    Aoun, P
    Greiner, TC
    Hock, L
    Vose, JM
    Gordon, BG
    Chan, WC
    Weisenburger, DD
    LABORATORY INVESTIGATION, 2001, 81 (01) : 155A - 155A
  • [22] Efficacy of Brentuximab-Vedotin (BV) in Peripheral T-Cell Lymphomas (PTCLs) Other Than Anaplastic Large Cell Lymphoma (ALCL)
    Zannori, Cristina
    Martiniani, Roberta
    Ascani, Stefano
    Liberati, Fabrizio
    Rauco, Annamaria
    Genua, Angelo
    Liberati, Anna Marina
    BLOOD, 2016, 128 (22)
  • [23] Treatment of T-cell anaplastic large cell lymphoma (ALCL) relapsing after autologous stem cell transplant (ASCT) with denileukin difitox (Ontak®).
    Mehta, AC
    Hutchison, RE
    Himpler, BS
    Zamkoff, KW
    Gentile, TC
    BLOOD, 2002, 100 (11) : 308B - 308B
  • [24] Depsipeptide, a histone deacetylase inhibitor, shows promising clinical activity in T-cell lymphomas
    Reddy, GK
    CLINICAL LYMPHOMA, 2004, 5 (01): : 15 - 16
  • [25] Clinicopathologic Features of Anaplastic Large Cell Lymphoma (ALCL), ALK- and CD30+Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL, nos): A Study from the North American T-Cell Lymphoma Consortium
    Macon, W. R.
    Maurer, M. J.
    Said, J.
    Rodig, S. J.
    Gascoyne, R. D.
    Dorfman, D. M.
    Ondrejka, S.
    Dogan, A.
    Hsi, E. D.
    LABORATORY INVESTIGATION, 2013, 93 : 343A - 343A
  • [26] Clinicopathologic Features of Anaplastic Large Cell Lymphoma (ALCL), ALK- and CD30+Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL, nos): A Study from the North American T-Cell Lymphoma Consortium
    Macon, W. R.
    Maurer, M. J.
    Said, J.
    Rodig, S. J.
    Gascoyne, R. D.
    Dorfman, D. M.
    Ondrejka, S.
    Dogan, A.
    Hsi, E. D.
    MODERN PATHOLOGY, 2013, 26 : 343A - 343A
  • [27] ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
    Savage, Kerry J.
    Harris, Nancy Lee
    Vose, Julie M.
    Ullrich, Fred
    Jaffe, Elaine S.
    Connors, Joseph M.
    Rimsza, Lisa
    Pileri, Stefano A.
    Chhanabhai, Mukesh
    Gascoyne, Randy D.
    Armitage, James O.
    Weisenburger, Dennis D.
    BLOOD, 2008, 111 (12) : 5496 - 5504
  • [28] Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
    De Smedt, Renate
    Peirs, Sofie
    Morscio, Julie
    Matthijssens, Filip
    Roels, Juliette
    Reunes, Lindy
    Lintermans, Beatrice
    Goossens, Steven
    Lammens, Tim
    Van Roy, Nadine
    Touzart, Aurore
    Jenni, Silvia
    Tsai, Yi-Chien
    Lovisa, Federica
    Mussolin, Lara
    Serafin, Valentina
    Van Nieuwerburgh, Filip
    Deforce, Dieter
    Uyttebroeck, Anne
    Tousseyn, Thomas
    Burkhardt, Birgit
    Klapper, Wolfram
    De Moerloose, Barbara
    Benoit, Yves
    Macintyre, Elizabeth
    Bourquin, Jean-Pierre
    Basso, Giuseppe
    Accordi, Benedetta
    Bornhauser, Beat
    Meijerink, Jules
    Vandenberghe, Peter
    Van Vlierberghe, Pieter
    HAEMATOLOGICA, 2019, 104 (01) : E17 - E20
  • [29] Pre-Clinical Study of Ibrutinib for the Treatment of T-Cell Lymphoma Using Magnetic Resonance Imaging (MRI) Assessment
    Allchin, Rebecca L.
    Kelly, Michael E.
    Mamand, Sami
    Barber, Ruth C.
    Ahearne, Matthew J.
    Wagner, Simon D.
    BLOOD, 2017, 130
  • [30] The gene expression profile of nodal T-cell lymphomas identifies a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH), and between CD30+ peripheral T-cell lymphoma and ALK-negative anaplastic large cell lymphoma (ALCL).
    de Leval, Laurence
    Rickman, David
    Thielen, Caroline
    de Reynies, Aurelien
    Huang, Yen-Lin
    Delsol, Georges
    Lamant, Laurence
    Molina, Thierry
    Berger, Francoise
    Gisselbrecht, Christian
    Xerri, Luc
    Gaulard, Philippe
    BLOOD, 2006, 108 (11) : 89A - 89A
12345